Alexion Pharmaceuticals, Inc. Gains 29.2%
Mon, Dec 14, 2020 at 05:33 PM
Alexion Pharmaceuticals, Inc. (ALXN:NASDAQ) soared at $156.31, a gain of 29.2%. The stock appeared on our News Catalysts scanner on Mon 14 Dec 20 at 05:02 PM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 50.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Alexion Pharmaceuticals, Inc. (ALXN:NASDAQ)
Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.
Top 10 Gainers:
- Arvinas, Inc. (ARVN:NASDAQ), 95.06%
- Veru Inc. (VERU:NASDAQ), 52.56%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 36.62%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 35.07%
- GasLog Partners LP (GLOP:NYSE), 31.18%
- Big Rock Partners Acquisition Corp. (BRPA:NASDAQ), 29.36%
- Alexion Pharmaceuticals, Inc. (ALXN:NASDAQ), 29.2%
- CooTek (Cayman) Inc. (CTK:NYSE), 28.4%
- Teligent, Inc. (TLGT:NASDAQ), 28.21%
- BioLineRx Ltd. (BLRX:NASDAQ), 26.97%